Prediction Case File
YouTubeTracking Live

CADL Candel Therapeutics Stock Analysis: Thursday Predicted Opening Price & 5 Catalysts - Will It Su

1 extracted signal · 0 resolved · 1 still active

StockInvest.us profile imageStockInvest.us02 Jul 2026, 13:21 UTC
Video preview for CADL Candel Therapeutics Stock Analysis: Thursday Predicted Opening Price & 5 Catalysts - Will It Su
Signals
1
Eligible signals in this source
Open
1
Still being tracked
Resolved
0
Evaluable outcomes
Successful
0
Canonical correct result
Failed
0
Canonical failed result
Resolved success
Not enough data
Open and excluded signals omitted
Source overview

AI-generated source summary

Candel Therapeutics (CADL) is exhibiting a strong upward trend, with its 50-day moving average at $167.08 and 200-day moving average at $152.36, both indicating bullishness. The stock's current price of $9.88 is above these averages, supported by higher-than-average volume of 58.18 million shares, signaling increased investor interest. The company's price-to-earnings ratio stands at $5.89 with a P/E of 30.09, suggesting consistent growth and a potentially fair valuation. Technical analysis forecasts a potential increase of 75.78% to 86.96% over the next three months, with projected returns ranging from $17.44 to $18.48. The 12-month outlook suggests a potential increase of 26.33% to 33.69%, with price targets between $12.47 and $13.11. This stock is identified as a buy candidate with a high risk profile due to significant daily price movements and a sell signal from a recent pivot top, with a potential further decline indicated if the price falls below $9.74 or $8.65.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.